Angiographic Restenosis in Coronary Bifurcations Treatment with Regular Drug Eluting Stents and Dedicated Bifurcation Drug-Eluting BiOSS Stents: Analysis Based on Randomized POLBOS I and POLBOS II Studies
Table 3
Balloon to artery ratio and late lumen loss.
BiOSS
DES
Balloon to artery ratio
BA/RD ratio
All
Restenotic
Nonrestenotic
All
Restenotic
Nonrestenotic
MV
1.14^
1.19#,^
1.13^
1.28,#,^
1.13#,^
1.29,#,^
MB
1.11”
1.01”
1.12
1.16”
1.05”
1.17”
SB
0.87
0.74
0.89#
0.86
0.72
0.87
Late lumen loss
MV
0.32 ± 0.24^
1.69 ± 1.22
0.15 ± 0.08#,^
0.24 ± 0.13
1.30 ± 1.01
0.15 ± 0.06
MB
0.38 ± 0.26”
1.30 ± 1.26
0.27 ± 0.13”
0.28 ± 0.19”
1.35 ± 0.77
0.19 ± 0.11
SB
0.15 ± 0.05
1.05 ± 0.84
0.04 ± 0.03
0.13 ± 0.07
0.58 ± 0.82
0.09 ± 0.05
BiOSS vs. DES in corresponding subgroups. #MV vs. MB, ^MV vs. SB, ”MB vs. SB.
